Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 89–89 | Cite as

Bleomycin/cisplatin/etoposide

Multiple cervical root resorption: case report
Case report
  • 11 Downloads
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

A 26-year-old woman developed multiple cervical root resorption following treatment with cisplatin, etoposide and bleomycin for ovarian cancer [routes not stated].

The woman, who was diagnosed with ovarian cancer at the age of 16 years, had received chemotherapy with five cycles of cisplatin 500 mg/m2 (20 mg/m2 daily for 5 daysin a cycle for 5 cycles), etoposide 2500 mg/m2 (100 mg/m2 daily for 5 days in a cycle for 5 cycles) and bleomycin 390 mg/m2 (30 mg/m2 daily for 3 days in the first 4 cycles and a single dose in the last cycle). Additionally, she had received treatment with triptorelin [Decapeptyl] and cyproterone [Androcur] for first 25 days of treatment. Three months after the initiation of treatment, she presented to the dentist due of increased mobility of 12th...

Reference

  1. Llavayol M, et al. Multiple Cervical Root Resorption in a Young Adult Female Previously Treated with Chemotherapy: A Case Report. Journal of Endodontics 45: 349-353, No. 3, Mar 2019. Available from: URL: http://doi.org/10.1016/j.joen.2018.12.012 - Spain

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations